Tarsus Pharmaceuticals, Inc. Initiates Phase 1 Callisto Trial of TP-05, a Novel, Oral, Non-Vaccine Therapeutic for the Prevention of Lyme Disease

Joey Cohen
Medication Adherence

Bud Bilanich
Success Coach

Stacey Gandler
Brand Nourishment

Brenda Snow
Authentic Patient Voice

Amy Giles
Increasing Engagement

Daniel Sontupe
Market Access

Matt Turner
Patient Affordability

Frank Burrell
Scientific Storytelling

Paul Theisen
Patient Acquisition

David Linetsky
Point-of-Care Marketing

Pat Purcell
Meeting Engagement

Suma Ramadas, PhD
Medical Affairs

Matthew Durham
Omnidynamic Marketing

Liz Kane
Impactful Strategy